查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595413

肺炎检测​​市场：按类型、方法、技术和最终用户划分 - 2025-2030 年全球预测

Pneumonia Testing Market by Type (Instruments, Reagents & Consumables), Method (Immunodiagnostics, Molecular Diagnostics, Point of Care Testing), Technology, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年肺炎检测市场价值为14.9亿美元，预计到2024年将达到15.8亿美元，复合年增长率为6.23%，到2030年将达到22.8亿美元。

肺炎检测​​涉及多种用于识别肺炎的方法，包括胸部 X 光检查等诊断影像技术、痰液培养等实验室检测以及检测细菌和病毒病原体的 PCR 等快速分子检测方法。肺炎检测​​的需求源于快速、准确的诊断的需要，以启动适当的治疗策略、限制感染的传播并降低与这种呼吸道疾病相关的死亡率。研究用途包括医院、门诊诊所和诊断实验室，最终用途包括医疗保健提供者、公共卫生组织和研究机构。推动肺炎检测市场的主要成长要素包括全球肺炎发病率上升、人们对感染疾病的认识不断提高、诊断方法的技术进步以及人工智慧在医疗诊断中的整合。对增强早期检测和即时决策的即时检测的需求不断增长，尤其是在资源有限的环境中，存在着巨大的机会。然而，先进诊断工具的高价格、监管障碍以及由于测试灵敏度和特异性的变化而可能出现错误结果等挑战可能会限制市场成长。此外，抗生素抗药性细菌的出现强调需要提高诊断准确性和快速检测能力。创新的重点可能是开发兼具高精度和简单性的高性价比、携带式检测设备，包括整合用于病原体检测的CRISPR技术和增强生物感测器技术。高科技公司和医疗保健提供者之间的合作可能会带来进一步的进步。肺炎检测​​市场有望实现动态和显着成长，这取决于持续的技术创新和解决当前限制的策略倡议。对于希望保持竞争优势并提高在肺炎诊断市场中的市场地位的公司来说，全面应对这些挑战并利用新机会至关重要。

主要市场统计
基准年[2023] 14.9亿美元
预测年份 [2024] 15.8亿美元
预测年份 [2030] 22.8亿美元
复合年增长率（%） 6.23%

市场动态：揭示快速发展的肺炎检测市场的关键市场洞察

供需的动态交互作用正在改变肺炎检测市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 随着世界老年人口的增加，肺炎盛行率不断增加
    • 医疗保健组织采取倡议提高对肺炎的认识
    • 人们对肺炎就地检验(POCT) 的兴趣日益浓厚
  • 市场限制因素
    • 肺炎综合检测高成本
  • 市场机会
    • 加强先进、快速、准确的肺炎诊断检测的开发
    • 扩大基于创新生物标誌物的测试的可能性
  • 市场挑战
    • 限制在资源有限的环境中进行测试

波特五力：驾驭肺炎检测市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解肺炎检测市场的外部影响

外部宏观环境因素对肺炎检测市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解肺炎检测市场的竞争状况

对肺炎检测市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵肺炎测试市场供应商的绩效评估

FPNV 定位矩阵是评估肺炎检测市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了肺炎检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对肺炎检测市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 随着世界各地老年人口的增加，肺炎发生率也随之增加
      • 医疗机构是否做出了任何努力来提高人们对肺炎的认识？
      • 肺炎就地检验(POCT) 的趋势不断成长
    • 抑制因素
      • 肺炎综合检测高成本
    • 机会
      • 先进、快速、准确的肺炎诊断检测技术开发进展
      • 扩大基于生物标记的创新测试的潜力
    • 任务
      • 在资源有限的环境中进行测试的机会有限
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 肺炎检测市场：依类型

  • 装置
  • 试剂/耗材

第七章 肺炎检测市场：依方法分类

  • 免疫诊断
  • 分子诊断
  • 就地检验

第八章肺炎检测市场：依技术分类

  • 酵素免疫分析法
  • 萤光
  • 免疫组织化学
  • 聚合酵素链锁反应
  • 西方墨点法

第九章肺炎检测市场：依最终用户分类

  • 诊断实验室
  • 医院/诊所

第十章 南北美洲肺炎检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太肺炎检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲肺炎检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Curetis GmbH
  • Danaher Corporation
  • DiaSorin SpA
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Hain Lifescience GmbH by Bruker Corporation
  • Hologic, Inc.
  • Intec Products, Inc.
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • OpGen Inc.
  • QIAGEN NV
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
  • True Bearing Diagnostics, Inc.
Product Code: MRR-69324464D0F1

The Pneumonia Testing Market was valued at USD 1.49 billion in 2023, expected to reach USD 1.58 billion in 2024, and is projected to grow at a CAGR of 6.23%, to USD 2.28 billion by 2030.

Pneumonia testing encompasses various diagnostic methods used to identify pneumonia, including imaging techniques like chest X-rays, laboratory tests like sputum cultures, and rapid molecular assays like PCR to detect bacterial and viral pathogens. The necessity of pneumonia testing is driven by the need for prompt and accurate diagnosis to initiate appropriate treatment strategies, reduce infection spread, and lower mortality rates associated with this respiratory condition. Applications are found across hospitals, outpatient clinics, and diagnostic laboratories, with end-use sectors including healthcare providers, public health organizations, and research institutions. Key growth factors driving the pneumonia testing market include the rising incidence of pneumonia globally, increased awareness about infectious diseases, technological advancements in diagnostic methods, and the integration of artificial intelligence in medical diagnostics. A significant opportunity lies in the expanding demand for point-of-care testing that enhances early detection and real-time decision-making, particularly in resource-constrained settings. However, challenges such as the high cost of advanced diagnostic tools, regulatory hurdles, and the potential for false results due to variability in test sensitivity and specificity can limit market growth. Additionally, emerging antibiotic-resistant strains of bacteria underscore the need for improved diagnostic accuracy and rapid testing capabilities. Innovations may focus on developing cost-effective, portable testing devices that combine high accuracy with simplicity, such as integrating CRISPR technology for pathogen detection or enhancing biosensor technology. Collaborations between tech firms and healthcare providers could unlock further advancements. The market for pneumonia testing is dynamic and poised for substantial growth, contingent on continued technological innovation and strategic initiatives that address current limitations. Comprehensively tackling these challenges and leveraging emerging opportunities will be vital for companies aiming to maintain competitive advantage and enhance market position in pneumonia diagnostics.

KEY MARKET STATISTICS
Base Year [2023] USD 1.49 billion
Estimated Year [2024] USD 1.58 billion
Forecast Year [2030] USD 2.28 billion
CAGR (%) 6.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pneumonia Testing Market

The Pneumonia Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of pneumonia with expanding geriatric population worldwide
    • Availability of initiatives by healthcare organizations to raise awareness about pneumonia
    • Growing inclination towards point-of-care testing (POCT) for pneumonia
  • Market Restraints
    • High cost of comprehensive pneumonia testing
  • Market Opportunities
    • Increasing development of advanced rapid and accurate diagnostic tests for pneumonia
    • Expanding potential for innovative biomarker-based tests
  • Market Challenges
    • Limited access to testing in resource-limited settings

Porter's Five Forces: A Strategic Tool for Navigating the Pneumonia Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pneumonia Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pneumonia Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pneumonia Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pneumonia Testing Market

A detailed market share analysis in the Pneumonia Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pneumonia Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pneumonia Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pneumonia Testing Market

A strategic analysis of the Pneumonia Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pneumonia Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Curetis GmbH, Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Hain Lifescience GmbH by Bruker Corporation, Hologic, Inc., Intec Products, Inc., Luminex Corporation, Meridian Bioscience, Inc., OpGen Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Quidel Corporation, Sekisui Diagnostics, LLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and True Bearing Diagnostics, Inc..

Market Segmentation & Coverage

This research report categorizes the Pneumonia Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Instruments and Reagents & Consumables.
  • Based on Method, market is studied across Immunodiagnostics, Molecular Diagnostics, and Point of Care Testing.
  • Based on Technology, market is studied across Enzyme Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry, Polymerase Chain Reaction, and Western Blot.
  • Based on End-user, market is studied across Diagnostic Laboratories and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of pneumonia with expanding geriatric population worldwide
      • 5.1.1.2. Availability of initiatives by healthcare organizations to raise awareness about pneumonia
      • 5.1.1.3. Growing inclination towards point-of-care testing (POCT) for pneumonia
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of comprehensive pneumonia testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing development of advanced rapid and accurate diagnostic tests for pneumonia
      • 5.1.3.2. Expanding potential for innovative biomarker-based tests
    • 5.1.4. Challenges
      • 5.1.4.1. Limited access to testing in resource-limited settings
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pneumonia Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables

7. Pneumonia Testing Market, by Method

  • 7.1. Introduction
  • 7.2. Immunodiagnostics
  • 7.3. Molecular Diagnostics
  • 7.4. Point of Care Testing

8. Pneumonia Testing Market, by Technology

  • 8.1. Introduction
  • 8.2. Enzyme Linked Immunosorbent Assay
  • 8.3. Immunofluorescence
  • 8.4. Immunohistochemistry
  • 8.5. Polymerase Chain Reaction
  • 8.6. Western Blot

9. Pneumonia Testing Market, by End-user

  • 9.1. Introduction
  • 9.2. Diagnostic Laboratories
  • 9.3. Hospitals & Clinics

10. Americas Pneumonia Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pneumonia Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pneumonia Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Becton, Dickinson and Company
  • 3. Bio-Rad Laboratories, Inc.
  • 4. bioMerieux SA
  • 5. Curetis GmbH
  • 6. Danaher Corporation
  • 7. DiaSorin S.p.A.
  • 8. Eurofins Scientific SE
  • 9. F. Hoffmann-La Roche Ltd
  • 10. Hain Lifescience GmbH by Bruker Corporation
  • 11. Hologic, Inc.
  • 12. Intec Products, Inc.
  • 13. Luminex Corporation
  • 14. Meridian Bioscience, Inc.
  • 15. OpGen Inc.
  • 16. QIAGEN N.V.
  • 17. Quest Diagnostics Incorporated
  • 18. Quidel Corporation
  • 19. Sekisui Diagnostics, LLC
  • 20. Siemens Healthineers AG
  • 21. Thermo Fisher Scientific Inc.
  • 22. Trinity Biotech PLC
  • 23. True Bearing Diagnostics, Inc.

LIST OF FIGURES

  • FIGURE 1. PNEUMONIA TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. PNEUMONIA TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PNEUMONIA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PNEUMONIA TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PNEUMONIA TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PNEUMONIA TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PNEUMONIA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PNEUMONIA TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. PNEUMONIA TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. PNEUMONIA TESTING MARKET, FPNV POSITIONING MATRIX, 2023